Paper3948308
Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantrone.
Dorr RT and 2 others. Cancer Chemother Pharmacol, 1986. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantrone. Papers, record 3948308. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3948308
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lack of experimental vesicant activity for the anticancer agents cisplatin, melphalan, and mitoxantrone.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anthraquinones | Major topic |
| Cisplatin | Major topic |
| Irritants | Major topic |
| Melphalan | Major topic |
| Skin Ulcer | Major topic |
| Animals | |
| Drug Evaluation, Preclinical | |
| Female | |
| Injections, Intradermal | |
| Mice | |
| Mice, Inbred BALB C | |
| Mitoxantrone |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA-17094 | NCI NIH HHS | United States | P01CA017094 | PubMed and NIH | NIH RePORTER |
| CA-23074 | NCI NIH HHS | United States | P30CA023074 | PubMed and NIH | NIH RePORTER |
| CA-31078 | NCI NIH HHS | United States | R01CA031078 | PubMed and NIH | NIH RePORTER |
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7442269 | Experimental model of doxorubicin extravasation in the mouse. | J Pharmacol Methods | 1980 | https://conductscience.org/library/papers/7442269 | PubMed |
| 2 | 3978648 | Disposition of mitoxantrone in cancer patients. | Cancer Res | 1985 | https://conductscience.org/library/papers/3978648 | PubMed |
| 3 | 6681733 | Full-thickness skin necrosis due to inadvertent interstitial infusion of cisplatin. | Cancer Treat Rep | 1983 | https://conductscience.org/library/papers/6681733 | PubMed |
| 4 | 6708933 | Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy. | Mol Pharmacol | 1984 | https://conductscience.org/library/papers/6708933 | PubMed |
| 5 | 6362875 | Clinical safety and tolerance of mitoxantrone (Novantrone). | Cancer Treat Rev | 1983 | https://conductscience.org/library/papers/6362875 | PubMed |
| 6 | 7397706 | Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. | Cancer Treat Rev | 1980 | https://conductscience.org/library/papers/7397706 | PubMed |
| 7 | 6678864 | Skin ulceration potential without therapeutic anticancer activity for epipodophyllotoxin commercial diluents. | Invest New Drugs | 1983 | https://conductscience.org/library/papers/6678864 | PubMed |
| 8 | 6102140 | Mechanism of DNA-binding of some aminoalkylamino-derivatives of anthraquinone and naphthacenequinone. | J Pharm Pharmacol | 1980 | https://conductscience.org/library/papers/6102140 | PubMed |
| 9 | 427822 | Hypersensitivity reactions to iv melphalan during treatment of multiple myeloma: Cancer and Leukemia Group B experience. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/427822 | PubMed |
| 10 | 3995475 | A clinical and pharmacokinetic study of isolated limb perfusion with heat and melphalan for melanoma. | Cancer | 1985 | https://conductscience.org/library/papers/3995475 | PubMed |
| 11 | 7083234 | Phase I study of a 5-day schedule of mitoxantrone (dihydroxyanthracenedione). | Cancer Treat Rep | 1982 | https://conductscience.org/library/papers/7083234 | PubMed |
| 12 | 953958 | Skin ulcers due to adriamycin. | Cancer | 1976 | https://conductscience.org/library/papers/953958 | PubMed |
| 13 | 6732077 | Intraperitoneal chemotherapy with melphalan. | Ann Intern Med | 1984 | https://conductscience.org/library/papers/6732077 | PubMed |
| 14 | 445964 | Kinetics of intravenous melphalan. | Clin Pharmacol Ther | 1979 | https://conductscience.org/library/papers/445964 | PubMed |
| 15 | 7042076 | Treatment of tissue extravasation by antitumor agents. | Cancer | 1982 | https://conductscience.org/library/papers/7042076 | PubMed |
| 16 | 481319 | Inapparent infiltrations associated with vindesine administration. | Med Pediatr Oncol | 1979 | https://conductscience.org/library/papers/481319 | PubMed |
| 17 | 6401597 | Mitomycin C extravasation injuries. | Cancer | 1983 | https://conductscience.org/library/papers/6401597 | PubMed |
| 18 | 7460190 | Phase I clinical trial f mitoxantrone: a new anthracenedione anticancer drug. | Cancer Chemother Pharmacol | 1980 | https://conductscience.org/library/papers/7460190 | PubMed |
| 19 | 326117 | Cis-diamminedichloroplatinum (II). A new anticancer drug. | Ann Intern Med | 1977 | https://conductscience.org/library/papers/326117 | PubMed |
| 20 | 7193090 | Cellulitis and fibrosis due to cis-diamminedichloroplatinum(II) (platinol) infiltration. | Cancer Treat Rep | 1980 | https://conductscience.org/library/papers/7193090 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40443182 | Comparison of outcomes in feline intermediate- to large-cell lymphoma treated with CMOP (cyclophosphamide, mitoxantrone, vincristine and prednisolone) instead of CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone). | J Feline Med Surg | 2025 | https://conductscience.org/library/papers/40443182 | PubMed |
| 8820798 | Mitoxantrone: a review of its pharmacological properties and use in acute nonlymphoblastic leukaemia. | Drugs Aging | 1996 | https://conductscience.org/library/papers/8820798 | PubMed |
| 8339386 | Extravasation injury potential of CI-980, a novel synthetic mitotic inhibitor. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8339386 | PubMed |
| 1711446 | Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer. | Drugs | 1991 | https://conductscience.org/library/papers/1711446 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3948308
GET https://conductscience.org/api/papers/v1/3948308/references?page=2